Skip to content
Facebook page opens in new windowTwitter page opens in new windowYouTube page opens in new window
Search:
Search
AdMeTech
AdMeTechAdMeTech

https://www.admetech.org/wp-content/uploads/2020/06/the-manogram-project-precision-prostate-care-for-every-man.png

  • Home/About Us
    • Organizational History and Landmark Accomplishments
    • The Manogram® Project
    • Mission
    • History
    • Board of Directors
    • Scientific Board
    • Honorary Committee
    • Testimonials
    • Public Recognition
    • Financial Information
    • Contact us / Take Action
  • Events
    • Annual Global Summit on Precision Diagnosis and Treatment for Prostate Cancer
    • Annual Prostate Cancer Awareness Day
    • Community Workshops: Prostate Cancer Awareness for High Risk Men
    • Host Committee for the Prostate Cancer Education and Awareness Program
    • Annual VIP Breakfast
    • Dance for a Cure of Prostate Cancer
  • Research Program
  • Education, Awareness & Advocacy
  • News
    • Media Coverage
    • Press Releases
    • Video Library
  • Donate
  • Home/About Us
    • Organizational History and Landmark Accomplishments
    • The Manogram® Project
    • Mission
    • History
    • Board of Directors
    • Scientific Board
    • Honorary Committee
    • Testimonials
    • Public Recognition
    • Financial Information
    • Contact us / Take Action
  • Events
    • Annual Global Summit on Precision Diagnosis and Treatment for Prostate Cancer
    • Annual Prostate Cancer Awareness Day
    • Community Workshops: Prostate Cancer Awareness for High Risk Men
    • Host Committee for the Prostate Cancer Education and Awareness Program
    • Annual VIP Breakfast
    • Dance for a Cure of Prostate Cancer
  • Research Program
  • Education, Awareness & Advocacy
  • News
    • Media Coverage
    • Press Releases
    • Video Library
  • Donate

Media Coverage

You are here:
  1. Home
  2. Media Coverage
Filter - All
AdMeTech In The News
Advocacy
Awareness and Education
Events
Other Prostate Cancer News
  • Read More
    Massachusetts State House News Service Coverage: AdMeTech Foundation's 13th Annual Prostate Cancer Awareness Day, March 31, 2022
    April 1, 2022
    Mariano Lends Voice To Prostate Cancer Awareness 2015 Campaign Helped Address Disparities in Plymouth County Sam Doran 3/31/22 5:59 PM STATE HOUSE, BOSTON, MARCH 31, 2022.....House Speaker Ronald Mariano on Thursday pointed to a boost in last year's budget for prostate cancer awareness as lawmakers pledged to continue their support for the fight against the disease and its inequities, and highlighted the positive effects that awareness campaigns can produce. At a virtual Prostate Cancer Awareness Day event, Mariano touted a $200,000 increase in fiscal 2022 for a line item that covers the costs of "a prostate cancer awareness, education and research program focusing on men with...
    READ MORE
  • Read More
    Brockton NAACP Forum - BCA TV
    March 6, 2020
    READ MORE
  • Read More
    Holbrook's "My Guy & Me" Health Fair
    November 20, 2019
    Experts urge manograms for men at Holbrook health fair Holbrook Health Fair
    READ MORE
  • Read More
    Prostate Cancer Awareness Day in Brockton, MA Sept 15, 2019
    September 19, 2019
    READ MORE
  • Read More
    CARE DISPARITIES HIGHLIGHTED AT PROSTATE CANCER EVENT
    May 1, 2019
    By Kaitlyn Budion STATE HOUSE NEWS SERVICE STATE HOUSE, BOSTON, APRIL 30, 2019.....Prostate cancer is a major public health issue in Massachusetts, especially in light of drastic racial disparities in care, lawmakers and advocates said Tuesday. "We must also take a hard look at racial and ethnic disparities in our health care delivery systems and find ways to ensure that everyone is getting a fair chance at a healthy future," said Senate President Karen Spilka. AdMeTech Foundation held its 11th annual Prostate Cancer Awareness Day, with speakers from the legislature and medical fields emphasizing the importance of early detection for prostate cancer. Prostate cancer...
    READ MORE
  • Read More
    Grand Rounds in Urology - Panel on Women in Urology
    April 19, 2019
    READ MORE
  • Read More
    Brockton Enterprise - "It can't be me"
    March 19, 2019
    Full coverage here
    READ MORE
  • Read More
    Brockton Community Access - NAACP Prostate Cancer Awareness 3-14-19
    March 18, 2019
    READ MORE
  • Read More
    Brockton Enterprise - "Black men at higher risk of prostate cancer"
    March 11, 2019
    Full coverage here
    READ MORE
  • Read More
    State Rep. Dan Cahill, Lynn Community Health Center push importance of early screenings for prostate cancer
    February 15, 2019
      https://www.itemlive.com/2019/02/11/state-rep-dan-cahill-lynn-community-health-center-push-importance-of-early-screenings-for-prostate-cancer/
    READ MORE
  • Read More
    NDT TV Coverage for over 110 Countries of 9th Annual Prostate Cancer Awareness Day at the State House
    June 19, 2017
    READ MORE
  • Read More
    Boston Globe's Stat Medical News: Thousands of men with prostate cancer get risky treatment they don’t need. New approaches could curb that
    June 15, 2017
    Thousands of men with prostate cancer get risky treatment they don’t need. New approaches could curb that By Sharon Begley @sxbegle  May 4, 2017 They look like glowing jade necklaces of such unearthly brilliance they could be a Ming emperor’s. But if Dr. Gerardo Fernandez is right, the green fluorescent images of prostate cells could be even more valuable, at least to the thousands of men every year who unnecessarily undergo aggressive treatment for prostate cancer. That’s because the glimmering images promise to show which prostate cancers are destined to remain harmless for the rest of a man’s life, and thus might spare...
    READ MORE
  • Read More
    WWLP/NBC Coverage of AdMeTech's 9th Annual Prostate Cancer Awareness Day
    June 15, 2017
    Lawmakers hold moment of silence during Prostate Cancer Awareness Day People of color and older men at higher risk for prostate cancer By Elisha Machado  bnjb j BOSTON, Mass. (WWLP) – Nearly three million men have prostate cancer. One in seven men is at risk for prostate cancer. State lawmakers are making prostate awareness and education a top public health priority. A moment of silence was held at the state’s annual Prostate Cancer Awareness Day for Senator Kenneth Donnelly, who battled prostate cancer and later died from a brain tumor earlier this year. 2.7 million American men currently live with prostate...
    READ MORE
  • Read More
    WBZ/CBS TV Coverage
    June 12, 2017
    The Annual Prostate Cancer Awareness Day (PCAD) at the Massachusetts State House was established in September 2009. This event resulted in the rapidly growing recognition of prostate cancer as a public health priority and support for increased research funding for the advancement of early diagnosis and treatment among key legislators in the Massachusetts General Court and US Congress.
    READ MORE
  • Read More
    Associated Press (WCVB) - Experts to discuss prostate cancer advances at Boston summit
    October 12, 2016
    BOSTON - Cutting-edge techniques for the diagnosis of prostate cancer will be the focus of what's being called a global summit this weekend in Boston. Experts are expected to discuss new and emerging prostate diagnostics at the conference. It's sponsored by the Boston-based nonprofit AdMeTech Foundation. Organizers say the summit will focus on breakthroughs that could have a significant impact on screening, early detection and treatment of the disease. Doctors from Brigham and Women's Hospital in Boston, Johns Hopkins Medical School in Baltimore and the Oregon Health and Science University Medical School will be among the featured speakers. Data from the U.S. Centers...
    READ MORE
  • Read More
    Boston study suggests big savings by using MRIs to diagnose prostate cancer
    October 12, 2016
    Sep 16, 2016   AdMeTech Foundation says it can save Massachusetts more than $200 million annually by using MRIs to diagnose aggressive prostate cancer. The finding is based on a clinical trial conducted at Brigham and Women’s Hospital in partnership with AdMeTech, a Boston-based non-profit to advance diagnosis and treatment of prostate cancer. At the First Global Summit on Precision Diagnosis for Prostate Cancer in Boston this weekend, the study found MRIs were able to better diagnose aggressive prostate cancer than traditionally used ultrasound techniques, saving men from unnecessary biopsies and surgeries. Using traditional ultrasound, doctors...
    READ MORE
  • Read More
    Improving Clinical Risk Stratification at Diagnosis in Primary Prostate Cancer: A Prognostic Modelling Study
    August 3, 2016
    August 2, 2016 Vincent J. Gnanapragasam Abstract Introduction Over 80% of the nearly 1 million men diagnosed with prostate cancer annually worldwide present with localised or locally advanced non-metastatic disease. Risk stratification is the cornerstone for clinical decision making and treatment selection for these men. The most widely applied stratification systems use presenting prostate-specific antigen (PSA) concentration, biopsy Gleason grade, and clinical stage to classify patients as low, intermediate, or high risk. There is, however, significant heterogeneity in outcomes within these standard groupings. The International Society of Urological Pathology (ISUP) has recently adopted a prognosis-based pathological classification that has yet to...
    READ MORE
  • Read More
    Boston Business Journal chose AdMeTech President and CEO Dr. Faina Shtern as one of the Women of Influence
    August 2, 2016
    Women of Influence: AdMeTech Foundation Chief Faina Shtern takes on prostate cancer. After she emigrated from the Soviet Union as a Jewish refugee escaping oppression, Faina Shtern knew what she wanted to do once she landed in America in the late 1970s: medical research. With a medical degree from Chemovets Medical School in the Ukraine, Shtern proceeded to pursue her dream, eventually working at a number of prestigious institutions over the years, including being appointed a clinical and research fellow at Massachusetts General Hospital and Harvard Medical School, where she subsequently became a faculty member.
    READ MORE
  • Read More
    Prostate cancer breakthrough could lead to new diagnostic tests and treatments
    July 29, 2016
    PUBLIC RELEASE: 28-JUL-2016Prostate cancer patients have been offered hope after scientists at Newcastle University, UK, have identified a new group of molecules that could be targeted to slow tumor growth. Experts used an advanced screening technique which found hundreds of genes were affected by the male hormone testosterone. It is believed this could lead to new diagnostic tests and treatments. Among the 700 genes identified was an important set that add sugar groups - known as glycans - to the surface of prostate cancer cells. This group has never been investigated before. Results of the research, published in...
    READ MORE
  • Read More
    Protein ZMYND8 tied to suppression of prostate cancer tumor metastasis
    July 29, 2016
    PUBLIC RELEASE: 28-JUL-2016 Study reveals protein's ability to block expression of metastasis-linked genes UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER PUBLIC RELEASE: 28-JUL-2016 Although it reads like European license plate number, a protein known as ZMYND8 has demonstrated its ability to block metastasis-linked genes in prostate cancer, according to a study at The University of Texas MD Anderson Cancer Center. The findings, resulting from cell line and mouse model studies, are published in the July 28 online issue of Molecular Cell. "These findings are important as cancer metastasis is a complicated process and is both devastating and clinically challenging,"...
    READ MORE
  • Read More
    Patients with low risk prostate cancer on active surveillance experience good quality of life
    July 29, 2016
    New York, NY, July 25, 2016 Researchers found no significant differences in health related quality of life between patients with low risk prostate cancer on active surveillance and men without the disease over 3 years of followup, according to new study in the Journal of Urology ELSEVIER HEALTH SCIENCES Active surveillance (AS) has become an increasingly important alternative to surgery, chemotherapy, or radiation treatment for men diagnosed with low risk prostate cancer. However, what is the impact of AS on health related quality of life (HRQoL) in patients selected or opting for this conservative form...
    READ MORE
  • Read More
    Switch from observation only to active treatment by prostate cancer patients varies by race/ethnicity
    July 29, 2016
    New York, NY, July 27, 2016Assessment of clinical and nonclinical factors indicates that black men on active surveillance are more likely to pursue active treatment, according to a new study published in The Journal of Urology®ELSEVIER HEALTH SCIENCESAlthough active surveillance, or watchful waiting, for patients with low risk prostate cancer has become an increasingly acceptable strategy for disease management, many men opt for definitive therapies such as radical prostatectomy or radiation therapy. A new study of more than 2,200 patients with low risk prostate cancer in an ethnically and economically diverse population...
    READ MORE
  • Read More
    New findings concerning hereditary prostate cancer
    July 29, 2016
    Date: July 11, 2016 It is a well-known fact that men with a family history of prostate cancer run an increased risk of developing the disease. The risk for brothers of men with prostate cancer is doubled. But a doubled risk of what, exactly? Prostate cancer my be an indolent condition that does not require treatment, or aggressive and fatal. Obviously, it makes a big difference whether a man has an increased risk of developing the indolent or the aggressive form, but until now these different risks have not been known. The Swedish researchers...
    READ MORE
  • Read More
    Prostate Cancer Isn’t Colorblind
    July 27, 2016
    By LANNIS HALL, ARNOLD D. BULLOCK, ANGELA L. BROWN and GRAHAM COLDITZJULY 27, 2016   St. Louis — In 1966, the Rev. Dr. Martin Luther King Jr. said, “Of all the forms of inequality, injustice in health care is the most shocking and inhuman.” While major advances have been made in health care, ethnic and racial disparities remain in the prevention, diagnosis and treatment of many illnesses, particularly prostate cancer. The risks facing African-Americans are shocking: They have the highest incidence of prostate cancer and the highest mortality rate from the disease of any ethnic or...
    READ MORE
  • Read More
    Era of Precision Oncology for Prostate Cancer 'Is Upon Us'
    July 21, 2016
    July 10, 2016 Bryant Furlow New biomarkers might revolutionize prostate cancer treatment, according to an educational presentation at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.1“We are now entering an era of personalized prostate cancer therapy informed by treatment-specific biomarkers, some of which can be performed using a blood test,” said Emmanuel S. Antonarakis, MD, associate professor of oncology at the Johns Hopkins Sidney Kimmel Cancer Center in Baltimore, Maryland. “One example is the AR-V7 biomarker, which can be interrogated from circulating tumor cells and may help direct patients away from...
    READ MORE
  • Read More
    PROSTATE CANCER ADVISOR: Familial Risk of Aggressive Prostate Cancer Quantified
    July 15, 2016
    Natasha Persaud, Digital Content Editor July 14, 2016 Swedish researchers have provided new estimates of the hereditary risk of significant prostate cancers (PCa) that may aid in patient counseling. Clinicians have long known that having a father or brother with
PCa doubles a man's risk for the disease, but many of these
cancers would turn out to be indolent. So Ola Bratt, MD, PhD,
of Lund University, Par Stattin, MD, PhD, of Umea University,
and colleagues used Prostate Cancer data Base Sweden, a
compilation of population-based registries that captures a vast
majority of PCa cases in the country, to estimate the...
    READ MORE
  • Read More
    Photoacoustic Imaging may improve prostate cancer monitoring and treatment
    July 15, 2016
    14-Jul-2016 8:05 AMNewswise — BUFFALO, N.Y. — While active surveillance is often recommended for patients with nonaggressive prostate cancer to reduce unnecessary treatment, the challenge for clinicians is to monitor and distinguish early-stage tumors from advanced cancers. A team of scientists led by researchers from Roswell Park Cancer Institute have demonstrated that photoacoustic imaging (PAI) may be an effective tool for more accurately viewing and monitoring prostate cancer. The new research has been published in the June 2016 issue of the Journal of Biomedical Optics. Photoacoustic imaging is an emerging noninvasive imaging modality...
    READ MORE
  • Read More
    Genetic testing can help deliver precision medicine to men with advanced prostate cancer
    July 7, 2016
    Date:July 7, 2016Genetic testing in men with advanced prostate cancer could pick up a significant proportion whose disease may be caused by inherited mutations in genes involved in repairing DNA damage, a major new study reveals. Testing prostate cancer patients for mutations in key DNA repair genes could identify those who may benefit from precision treatments that specifically target DNA repair weaknesses in cancer cells. Some 12% of men with advanced prostate cancer in the study population were found to have inherited mutations in one of several genes involved in DNA repair — such...
    READ MORE
  • Read More
    Leading researchers recommend major change in prostate cancer treatment
    July 7, 2016
    Laurie McGinley July 6Leading American and British cancer researchers are urging that all men with advanced prostate cancer strongly consider being tested for inherited gene mutations -- both to help steer their treatment and to alert family members who themselves might be at increased risk for a range of cancers. This new recommendation, which represents a major change in approach, was prompted by a study published Wednesday in the New England Journal of Medicine. The researchers found that almost 12 percent of men with advanced cancer had defects in genes that are designed to...
    READ MORE
  • Read More
    Brockton Community Access: AdMeTech & June 17th Event Interview
    June 22, 2016
    June 2nd, 2016 Dr. Faina Shtern of the AdMeTech Foundation interviews with Brockton Community Access to discuss men's health in Brockton, Massachusetts and the Father's Day June 17th Event.
    READ MORE
  • Read More
    A prostate cancer summit is set for Friday night in Brockton
    June 16, 2016
    By Marc Larocque Posted Jun. 15, 2016 at 4:18 PM The Brockton NAACP, Good Samaritan Medical Center and the AdMeTech foundation are hosting a prostate cancer awareness event on Friday night at VFW Post 1046 at 283 North Quincy St. “It behooves us to provide an opportunity for people to be aware of what they have to do to maintain prostate health,” said Stephen Bernard, of the Brockton NAACP. BROCKTON – Early detection of prostate cancer can save lives, including those of black men in Brockton who face a disproportionately higher risk. That’s the fundamental message...
    READ MORE
  • Read More
    More Men With Early Prostate Cancer Are Choosing to Avoid Treatment
    May 25, 2016
    By GINA KOLATA May 24, 2016 Seemingly overnight, treatment of men with early-stage prostate cancer has undergone a sea change. Five years ago, nearly all opted for surgery or radiation; now, nearly half are choosing no treatment at all. The approach is called active surveillance. It means their cancers are left alone but regularly monitored to be sure they are not growing. Just 10 percent to 15 percent of early-stage prostate cancer patients were being treated by active surveillance several years ago. Now, national data from three independent sources consistently finds that 40 percent to 50 percent...
    READ MORE
  • Read More
    New model for prostate cancer health being launched in Brockton
    May 5, 2016
    The Brockton Area Branch NAACP is teaming up with the Boston-based AdMeTech Foundation to implement a new model of community education aimed at men facing decisions on screenings, diagnosis and treatment for prostate cancer. By Marc Larocque Posted May 4, 2016 at 4:16 PM BROCKTON – A new targeted effort to spread awareness about prostate cancer is underway in Brockton, with the local chapter of the NAACP rallying to tell the community how important it is to confront the disease, citing statistics showing that it has a disproportionate effect on black men. The Brockton Area Branch...
    READ MORE
  • Read More
    Baker, Ireland share stories at prostate cancer awareness event
    April 1, 2016
    By Andy Metzger/State House News Service Posted Mar. 31, 2016 at 2:58 PM BOSTON - Gov. Charlie Baker and the former chief justice of the Supreme Judicial Court shared personal stories on Thursday about prostate cancer, the second most prevalent type of cancer for men after skin cancer. Roderick Ireland, the former chief justice, recalled how he insisted on receiving a biopsy after reading a book his friend Wayne Budd sent him about an author's experience with the disease. The former U.S. Attorney of Massachusetts, Budd is the senior counsel in the litigation department of Goodwin Proctor. Ireland, who is black,...
    READ MORE
  • Read More
    Baker, Ireland share stories at prostate cancer awareness event
    April 1, 2016
    By Andy Metzger/State House News Service Posted Mar. 31, 2016 at 2:58 PM BOSTON - Gov. Charlie Baker and the former chief justice of the Supreme Judicial Court shared personal stories on Thursday about prostate cancer, the second most prevalent type of cancer for men after skin cancer. Roderick Ireland, the former chief justice, recalled how he insisted on receiving a biopsy after reading a book his friend Wayne Budd sent him about an author's experience with the disease. The former U.S. Attorney of Massachusetts, Budd is the senior counsel in the litigation department of Goodwin Proctor. Ireland, who is black, told the...
    READ MORE
  • Read More
    Baker, Ireland share stories at prostate cancer awareness event
    April 1, 2016
    Andy Metzger, State House News Service Published: March 31, 2016, 4:07 pm Massachusetts Gov. Charlie Baker reacts as he gets a buzz cut during a fundraising drive at Granite Telecommunications in Quincy, Mass., Tuesday, April 7, 2015 in support of the Dana-Farber Cancer Institute. Baker joined more than 500 company employees who shaved their heads to raise over $3.5 million for cancer research. (AP Photo/Elise Amendola) BOSTON (STATE HOUSE) – Gov. Charlie Baker and the former chief justice of the Supreme Judicial Court shared personal stories on Thursday about prostate cancer, the second most prevalent type of cancer for men after skin...
    READ MORE
  • Read More
    State House event to highlight prostate cancer awareness
    April 1, 2016
    By Megan Bard UMass Medical School Communications March 30, 2016 Mitchell Sokoloff, MD The event, hosted by the AdMeTech Foundation, will include a panel discussion; free counseling on screening, diagnosis and treatment; and exhibits on prostate health from 10 a.m. to 2 p.m. Dr. Sokoloff, chair and professor of urology, will help moderate the expert panel on prostate cancer. He will also share some of his work in the Worcester region that focuses on increasing access to care and awareness of prostate health for those determined to be at higher risk. Sokoloff said there have been long-standing issues with awareness of and access to...
    READ MORE
  • Read More
    Baker, Ireland share stories at prostate cancer awareness event
    April 1, 2016
    By Andy Metzger/State House News Service Posted Mar. 31, 2016 at 2:58 PM BOSTON - Gov. Charlie Baker and the former chief justice of the Supreme Judicial Court shared personal stories on Thursday about prostate cancer, the second most prevalent type of cancer for men after skin cancer. Roderick Ireland, the former chief justice, recalled how he insisted on receiving a biopsy after reading a book his friend Wayne Budd sent him about an author's experience with the disease. The former U.S. Attorney of Massachusetts, Budd is the senior counsel in the litigation department of Goodwin Proctor. Ireland, who is black, told the...
    READ MORE
  • Read More
    NAACP to host workshop on ending prostate cancer in Bedford
    March 21, 2016
    Posted Sep. 24, 2015 at 10:29 AM Updated Sep 24, 2015 at 12:04 PM BEDFORD Faina Shtern, president and CEO of the AdMeTech Foundation, will host a workshop on ending prostate cancer from 2 to 3 p.m. Sept. 26 at the DoubleTree Boston Bedford Hotel, 44 Middlesex Turnpike. This event is in honor of National Prostate Cancer Awareness Month and is focused on ending prostate cancer as a health care disparity in black men in Massachusetts. The event will be held during the annual meeting for the New England Area Conference, National Association for the Advancement of Colored People. The goal of the...
    READ MORE
  • Read More
    Overcoming the Limitations for Prostate Cancer Diagnosis
    February 29, 2016
    By: Srinivas Vourganti, MD Monday, February 29, 2016 The current standard of care for prostate cancer diagnosis typically involves an initial screening step principally utilizing serum blood testing — mainly total prostate-specific antigen (PSA) and others, such as free PSA, PSA isoforms — and a follow-up confirmatory test involving biopsy tissue sampling (systematic transrectal ultrasound guided biopsy) for pathologic evaluation. The trouble with this common strategy is that both steps are imprecise. Serum blood testing, while useful, is well known to yield both false positive and false negative results. This has led to significant public health controversy, including some national guideline recommendations...
    READ MORE
  • Read More
    Screening for prostate cancer a personal decision for men
    February 29, 2016
    (photo: Marc Levy/Associated Press) Pennsylvania Gov. Tom Wolf discusses his diagnosis of what he called treatable prostate cancer with members of the media in his Capitol offices, in Harrisburg, Pa. By Adam Smeltz / Pittsburgh Post-Gazette Jolted by Gov. Tom Wolf’s diagnosis, more Pennsylvanians may be taking a close look at their risks for prostate cancer, several specialists predicted Wednesday. While routine screening can help save lives, the doctors said, aggressive tests and therapies aren’t for everyone. Among the 10,000 men diagnosed with the disease in Pennsylvania each year, about a quarter will undergo only observation, not immediate treatment, according to estimates from...
    READ MORE
  • Read More
    Gov. Tom Wolf diagnosed with treatable form of prostate cancer
    February 29, 2016
    Gov. Tom Wolf diagnosed with treatable form of prostate cancer Gov. Tom Wolf to discuss his diagnosis of prostate cancer at a news conference this morning. (File photo/Mark Pynes | mpynes@pennlive.com) By Jan Murphy | jmurphy@pennlive.com on February 24, 2016 at 10:19 AM, updated February 24, 2016 at 5:58 PM Gov. Tom Wolf held a news conference Wednesday morning along with his wife, Frances, to discuss his recent diagnosis of early stages of prostate cancer. Gov. Tom Wolf announced he has prostate cancer on Feb. 24, 2016. Here are some facts about the disease. Gov. Wolf's cancer strikes one out of every seven men, one man...
    READ MORE
  • Read More
    Fewer Men Are Getting Prostate Cancer Blood Tests, And That May Not Be a Good Thing
    November 18, 2015
    Fewer Men Are Getting Prostate Cancer Blood Tests, And That May Not Be a Good Thing Some experts now advise men not to get the blood test that can pick up prostate cancer, but that may be putting certain men at risk Health advice is often confusing — and conflicting — and nothing proves that better than recommendations about prostate cancer screening. The prostate specific antigen (PSA) blood test can pick up early signs of tumors in the prostate, but it’s not 100% reliable. And prostate tumors tend to be slow growing and less aggressive than other types of tumors, so...
    READ MORE
  • Read More
    Studies Find Declines in Screening and Early Detection of Prostate Cancer
    November 17, 2015
    Studies Find Declines in Screening and Early Detection of Prostate Cancer By DENISE GRADYNOV. 17, 2015 Fewer men are being screened for prostate cancer, and fewer early-stage cases are being detected, according to two studies published Tuesday in the Journal of the American Medical Association. The number of cases has dropped not because the disease is becoming less common but because there is less effort to find it, the researchers said. The declines in both screening and incidence “could have significant public health implications,” the authors of one of the studies wrote, but they added that it was too soon to tell whether...
    READ MORE
  • Read More
    Groundbreaking work on prostate cancer genetics
    November 9, 2015
    Groundbreaking work on prostate cancer genetics National Cancer Institute and National Genome Project announced that the Cancer Genome Atlas (TCGA) Research Network produced groundbreaking results in research on genetic alterations in prostate cancer.  These findings identified seven drivers of of prostate cancer, which may play an important role in clinical prognosis and management. This is of particular importance now, when over 80% of new cases of prostate cancer are diagnosed at a localized stage. Thus, the central challenge in patient care is to distinguish lethal cancer from slow-growing,...
    READ MORE
  • Read More
    Federal US PSTF Task Force is updating its recommendation against PSA screening
    November 4, 2015
    Federal US PSTF Task Force is updating its recommendation against PSA screening   From AdMeTech Foundation – November 3, 2015 The U.S. Preventive Services Task Force (USPSTF) announced on October 29, 2015 that it will re-evaluate and update its recommendation against PSA screening for prostate cancer made in 2011-2012. Read more In October 2011, AdMeTech Foundation expressed concerns about these guidelines and submitted a public response: https://www.admetech.org/us-preventive-services-task-force-us-pstf/ Like any other medical tests, PSA screening is not perfect and it is associated with not only benefits, but also risks. PSA cannot distinguish lethal prostate cancer from benign diseases and low risk (“harmless”) malignancies, which are...
    READ MORE
  • Read More
    Reduced prostate screening could miss advanced tumors
    September 25, 2015
            Reduced prostate screening could miss advanced tumors By STEVEN REINBERG      September 24, 2015, 8:30 AM Relaxed guidelines on prostate cancer screening may delay diagnosis and treatment of aggressive tumors, a new study suggests. In 2011, the U.S. Preventive Services Task Force recommended against routine prostate specific antigen (PSA) testing, to curb over-diagnosis and overtreatment of prostate cancer. Since then, PSA screening has dropped by 28 percent, the researchers report. "On the positive side, there is a lot of prostate cancer that we don't need to know about," said lead researcher Dr. Daniel Barocas, an assistant professor of urologic surgery at Vanderbilt...
    READ MORE
  • Read More
    Hispanic men urged to get prostate exams
    September 21, 2015
    Hispanic men urged to get prostate exams By Aneri Pattani GLOBE CORRESPONDENT  SEPTEMBER 21, 2015 Local doctors and advocates spoke with about 1,000 parishioners Sunday at the Congregación León de Judá in the South End about the high risk of death from prostate cancer for Hispanic men in Boston. The event, which was organized by AdMeTech, a Boston-based nonprofit that focuses on the advancement of prostate cancer care, aimed to increase awareness about screening and the high death toll from prostate cancer in the Hispanic community. In Boston, prostate cancer mortality for Hispanic men is 40 percent higher than the state average, said Dr. Faina...
    READ MORE
  • Read More
    AdMeTech Foundation and NAACP,NEAC joined Urban Update, 7News Boston WHDH-TV
    September 17, 2015
    AdMeTech Foundation and NAACP, NEAC joined Urban Update, 7News Boston September is Prostate Cancer Awareness Month. As part of AdMeTech Foundation efforts to raise awareness on prostate cancer they were invited to be guests on Channel 7 Urban Update with host Byron Barnett. Dr. Faina Shtern, CEO and Founder, AdMeTech Foundation and Juan Cofield, President, NAACP, NEAC discussed Prostate Cancer as a health care disparity for Black (including Hispanic) men in Boston. 
    READ MORE
  • Read More
    New molecular targets (ARF GTPases) can improve early diagnosis of prostate cancer and prediction of its progression
    July 17, 2015
    Prostate cancer (PCa) is the most common cancer in men (excluding non melanoma skin cancer) in the UK with over 40,000 cases diagnosed each year (CancerResearchUK ). However, for some men with early stage PCa that is confined to the prostate the disease may never be life threatening and can follow and indolent course which does not require urgent or invasive treatment. Unfortunately prostate specific antigen levels (PSA), Gleason score and clinical and pathological grading used to diagnose and grade PCa lack the specificity or sensitivity to distinguish between patients with indolent PCa and those requiring radical treatment. Changes...
    READ MORE
  • Read More
    Diabetes drug targeting glucose transport may impact treatment of prostate cancer and highlights potential importance of PET imaging
    July 17, 2015
    UCLA scientists have identified a new mechanism that delivers a key substance that fuels the growth of pancreatic and prostate cancer cells, a finding that offers new hope in the fight against two of the deadliest forms of the disease. Cancer cells require high amounts of the sugar glucose to survive and grow, and long-standing research has established passive glucose transporters, known as GLUTS, as the primary method the body uses to deliver glucose to tumors. But the results of a three-year study by UCLA researchers, demonstrated that pancreatic and prostate cancer cells also utilize glucose from sodium-dependent glucose transporters known...
    READ MORE
  • Read More
    US Senator Nelson (D-FLA) , aged 72, announced that routine prostate cancer screening enabled early diagnosis and successful treatment.
    July 17, 2015
    Democratic Sen. Bill Nelson of Florida will undergo prostate cancer surgery at a local hospital Monday, his office said Thursday. Doctors found the cancer during a routine exam, according to a release from his office. It said Nelson had no symptoms and "extensive" scans showed no evidence the cancer has spread outside the prostate. Nelson, 72, of Orlando, said the diagnosis does not affect his plan to run for re-election to a fourth term in 2018. "I've been blessed with good health, which has allowed me the great privilege of public service —and I look forward to continuing serving our country and...
    READ MORE
  • Read More
    Research shows reduction in prostate cancer overtreatment
    July 17, 2015
    In the analysis of 10,472 men from 1990 to 2013, use of surveillance for low-risk disease rose sharply in 2010 through 2013, to 40% of cases. Use of surveillance had previously remained low, at between 7% and 14%, from 1990 through 2009. Dr. Matthew Cooperberg did the study with Dr. Peter Carroll, both of the University of California, San Francisco, to analyze recent trends in community-based patterns of managing localized prostate cancer. Data from the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) were used. This is a national registry of men with prostate cancer cared for since 1995 across...
    READ MORE
  • Read More
    Researchers discovered a molecule (DNA-PKcs) promoting prostate cancer metastases and opening new pathways for drug development and testing
    July 17, 2015
    For the first time, a single molecule has been identified that could be central to the mechanism of spread by prostate cancer. The findings could lead to a new prostate cancer drug target. The study is published in the journal Cancer Cell and was completed by researchers from the Thomas Jefferson University in Philadelphia, PA. The results offer a target for the development of a drug that could prevent metastasis in prostate cancer - and possibly other cancers, too. Karen Knudsen, PhD, director of the Sidney Kimmel Cancer Center at Thomas Jefferson University, says: "Finding a way to halt or prevent cancer metastasis has...
    READ MORE
  • Read More
    New York Times: Bring PSA Screening Back
    July 6, 2015
    FOR years, research on prostate cancer has sought an approach to screening that is more individualized than a one-size-fits-all measurement of the level of prostate-specific antigen in a man’s blood. These efforts are now paying off. That’s why it’s time to re-evaluate the nation’s current approach to prostate cancer. Even though we anticipate 221,000 new diagnoses this year, and 28,000 deaths, recommendations drafted in 2010 and finalized in 2012 strongly discourage PSA screening men without symptoms for this disease. Those decisions didn’t take into account adaptations that urologists have made to help better identify patients likely to develop deadly prostate cancers....
    READ MORE
  • Read More
    NCCN Guidelines for Prostate Cancer Screening 2015 Endorse PSA and its Advanced Versions
    July 6, 2015
    The 2015 update of the guidelines for prostate cancer from the National Comprehensive Cancer Network (NCCN) marks the 20th annual edition of the guidance. The update contains three major changes, which are related to imaging, molecular testing, and the systemic treatment of castration-resistant disease, said James Mohler, MD, who chairs the NCCN panel for prostate cancer, in an interview with Medscape Medical News. The section on imaging has new recommendations on the use of PET for bone scans and on a type of MRI for the imaging of the gland. The revisions reflect "newly appreciated uses of imaging," said Dr Mohler, who is...
    READ MORE
  • Read More
    A prostate surgeon's warning: Federal guidelines against PSA test put men in danger
    July 6, 2015
    The U.S. Preventive Services Task Force (USPSTF) recommends against PSA (prostate specific antigen) screening for prostate cancer. The task force currently gives PSA screening a grade D, meaning that there is moderate or high certainty that the PSA test has no benefit or that the harms outweigh the benefits. This recommendation was first issued in 2011. What’s wrong with the USPSTF guidelines? In regards to population screening, the African-American male population is ignored, as well as the effect of family history and morbidity associated with prostate cancer. However, African-American men are 56 percent more likely to develop prostate cancer and more...
    READ MORE
  • Read More
    Hormone Treatment May Improve Survival in Men with Incurable Prostate Cancer
    June 26, 2015
    Australian researchers have discovered that men with incurable prostate cancer, but without symptoms, who received immediate hormone treatment on the TROG 03.06 (TOAD) clinical trial, had an increase in survival over those who delayed treatment – with 80% still alive after six years, compared to 65% of men for whom treatment was delayed until they showed further symptoms or signs of progression. The randomised, phase III trial, which was led by Australia, with contributions from New Zealand and Canada, was conducted to determine if immediate intervention with androgen deprivation therapy (ADT) would improve overall survival, compared with delayed ADT in...
    READ MORE
  • Read More
    Clinical Trial Shows Promise of Adjuvant Chemotherapy in High Risk Prostate Cancer
    June 26, 2015
    For the first time, a large randomized trial has suggested that overall survival is improved by the addition of adjuvant chemotherapy to androgen suppression and radiotherapy in men with localized, high-risk, hormone-sensitive prostate cancer. Docetaxel has been used to treat metastatic hormone-resistant prostate cancer for a number of years, and this new study—RTOG 0521—suggests that moving it up earlier in the course of treatment to the adjuvant setting may extend the lives of men with high-risk, hormone-sensitive prostate cancer.1 Results of RTOG 0521 are part of an emerging story, suggesting that docetaxel can be used earlier in the course of...
    READ MORE
  • Read More
    Prostate Cancer Expert Expresses Major Concerns About Standard Biopsy
    June 26, 2015
    Too many men are getting the all-clear for prostate cancer when in fact they have the disease, say doctors, who are calling for an overhaul of testing techniques. Professor Stephen Langley, a prostate cancer expert, blames the misdiagnoses on inaccurate biopsies. Under current guidelines from NICE (National Institute for Health and Care Excellence), men with abnormally high levels of prostate specific antigen (PSA), a protein produced by the prostate gland, should be offered a test called trans-rectal ultrasound (TRUS) biopsy. Here, doctors take tissue samples by passing special needles via a probe in the rectum. Read More
    READ MORE
  • Read More
    Emory University Reports Research on Improving Prostate Cancer Diagnosis
    June 26, 2015
    A central challenge in diagnosing and treating prostate cancer is distinguishing fast from slow, aggressive from indolent. Consider the experience of Gerald Alexander. A former Air Force surgical service specialist who completed several tours of duty in Iraq and Afghanistan, Alexander was preparing to retire from the military and make a transition to teaching high school in Warner Robins, Georgia. As part of a routine pre-retirement physical exam, his doctors performed a PSA (prostate specific antigen) test, and the PSA level was high. A biopsy in early 2013 revealed the clear presence of cancerous cells. The Gleason score (see glossary),...
    READ MORE
  • Read More
    Novel Ultrasound Imaging for Prostate Cancer Reported
    June 26, 2015
    ROCHESTER, N.Y. — Hans Schmitthenner, a research scientist at Rochester Institute of Technology, hopes to make detecting prostate cancer — the second leading cause of cancer deaths among men — less of a guessing game. Non-cancerous cells as well as cancerous cells can produce elevated PSA levels in the test for prostate-specific antigens commonly used to find signs of prostate cancer. Just a quarter of those patients who have a biopsy taken because of heightened PSA levels actually have prostate cancer, according to the National Cancer Institute. Another procedure, the digital rectal exam, which tries to detect cancerous growths by hand,...
    READ MORE
  • Read More
    Genomic's Prostate Cancer Test Recommended by Palmetto
    May 29, 2015
    Genomic Health, Inc.(GHDX - Analyst Report) recently declared that Medicare contractor, Palmetto GBA, has issued a draft local coverage determination (LCD) for its Oncotype DX prostate cancer test. The draft LCD recommends coverage and reimbursement of the Oncotype DX prostate cancer test for applicable Medicare patients across the U.S. This should encourage the identification of those patients with early-stage, needle biopsy proven prostate cancer, who can be managed conservatively rather than being treated with definitive surgery or radiation therapy. As one of the leading molecular diagnostic providers with special focus on cancer treatment, this news marks a crucial step toward strengthening...
    READ MORE
  • Read More
    International study of advanced prostate cancer genome finds abundance of potential targets for drug therapy
    May 22, 2015
    International study of advanced prostate cancer genome finds abundance of potential targets for drug therapy The first major effort to canvas the genomic landscape of advanced prostate cancer has revealed that many patients may carry some type of genetic abnormality that can be targeted with existing or potential drugs. The finding, reported today by a Stand Up to Cancer-Prostate Cancer Foundation Dream Team in the May 21, 2015, edition of the journalCell, is based on an analysis of tumor samples from 150 men with metastatic prostate cancer that no longer responded to standard hormone-blocking therapy. Eight institutions from the United States...
    READ MORE
  • Read More
    UnivisionTV: Cancer de Prostata
    April 23, 2015
    Univision TV, which has an extensive outreach in the Massachusetts Hispanic community, covered 7th Annual Prostate Cancer Awareness Day, highlighting 40% higher mortality in the Hispanic community in Boston compared to state average and the importance of early detection in saving lives. This coverage featured several event speakers, including Massachusetts Governor Charlie Baker; Felix Arroyo, Boston’s Chief of Health and Human Services; Dr. Faina Shtern, President and CEO of AdMeTech Foundation; and Dr. Adam Feldman, a prostate cancer experts, who represented Department of Urology, Massachusetts General Hospital, Harvard Medical School and Men’s Health Committee, Massachusetts Medical Society.  More Prostate Cancer...
    READ MORE
  • Read More
    We All Agree: State House Leaders Call for Greater Prostate Cancer Awareness
    April 23, 2015
    Elected Officials, Prostate Cancer Experts, Advocates, Celtics Legend Cedric Maxwell Come Together for Prostate Cancer Awareness Day BOSTON, April 16, 2015 BOSTON, April 16, 2015 /PRNewswire-USNewswire/ -- In an effort to highlight the critical importance of early detection and treatment of prostate cancer, elected officials, medical experts, and advocates today came together for AdMeTech Foundation's 7th Annual Prostate Cancer Awareness Day. The featured speakers included Governor Charlie Baker, Senate President Stanley Rosenberg, Senate Majority Leader Harriette Chandler, NAACP New England Area Conference President Juan Cofield, Marathon legend and prostate cancer survivor Bill Rodgers, and Celtics great Cedric Maxwell. Maxwell dedicated his participation to...
    READ MORE
  • Read More
    Elected officials, prostate cancer experts, advocates, Celtics Legend Cedric Maxwell come together for Prostate Cancer Awareness Day
    April 16, 2015
    Elected officials, prostate cancer experts, advocates, Celtics Legend Cedric Maxwell come together for Prostate Cancer Awareness Day In an effort to highlight the critical importance of early detection and treatment of prostate cancer, elected officials, medical experts, and advocates today came together for AdMeTech Foundation’s 7th Annual Prostate Cancer Awareness Day. The featured speakers included Governor Charlie Baker, Senate President Stanley Rosenberg, Senate Majority Leader Harriette Chandler, NAACP New England Area Conference President Juan Cofield, Marathon legend and prostate cancer survivor Bill Rodgers, and Celtics great Cedric Maxwell. Maxwell dedicated his participation to K.C. Jones, his former coach and Hall of...
    READ MORE
  • Read More
    Gov. Charlie Baker proclaims Massachusetts Prostate Cancer Awareness Day
    April 16, 2015
    Gov. Charlie Baker proclaims Massachusetts Prostate Cancer Awareness Day By Anne Gerald Flynn BOSTON - Gov. Charlie Baker has proclaimed today Massachusetts Prostate Cancer Awareness Day and he and nine other legislators, including Representatives Benjamin Swan (D-Springfield), and Stephen Kulik, D-Worthington, who was diagnosed with prostate cancer in 2002, appear in a related video, "We All Agree 2015," by the non-profit AdMeTech Foundation. There is also a video about the importance of talking to a doctor about prostate screening on the website of the state Department of Public Health. There are two tests for prostate cancer. Here are some facts about prostate cancer...
    READ MORE
  • Read More
    Education Programs Needed for Prostate Cancer
    April 15, 2015
    Disease is more common, lethal than breast cancer BILL RODGERS Apr 15, 2015 TOOO MANY MEN are still trying to run away but they cannot hide from prostate cancer. I was one of those men—until a diagnosis of prostate cancer in 2008 brought my racing plans to a screeching halt. After having competed in over 60 marathons, in harsh weather conditions and against some of the fastest men in the world, I am proud of running and winning seven major events on five continents. But I couldn’t run and hide from prostate cancer. Winning my battle...
    READ MORE
  • Read More
    Lawmakers Team Up to Push Prostate Cancer Awareness
    April 15, 2015
    LAWMAKERS TEAM UP TO PUSH PROSTATE CANCER AWARENESS   By Gintautas Dumcius STATE HOUSE NEWS SERVICE STATE HOUSE, BOSTON, APRIL 15, 2015.....The House and Senate may be at odds over rules that cover the flow of legislation, but lawmakers from both branches are in agreement for more awareness of early detection of prostate cancer. Joined by Gov. Charlie Baker, House and Senate legislators from both parties appear in a video that's being released Wednesday, a day before the seventh annual Prostate Cancer Awareness Day. Beacon Hill leaders are expected to attend Prostate Cancer Awareness Day event in the Great Hall at 2 p.m....
    READ MORE
  • Read More
    We All Agree 2015 Video
    April 14, 2015
    We All Agree 2015: New Video Features Massachusetts Governor, Democratic and Republican Legislative Leaders Calling for Prostate Cancer Awareness BOSTON, MA, April 15, 2015— Massachusetts Governor Charlie Baker and nine leading legislators appear together in a bipartisan video, “We All Agree 2015,” which was released today by the non-profit AdMeTech Foundation, in advance of the 7th Annual Prostate Cancer Awareness Day at the State House on April 16. In the video, Governor Baker and leading Republican and Democratic legislators in the House and Senate call on Massachusetts to lead the fight against this most common major cancer and health care disparity. This is the...
    READ MORE
  • Read More
    Legislators, Medical Experts, Advocates Launch Statewide Prostate Cancer Education and Awareness Program
    April 13, 2015
    Legislators, Medical Experts, Advocates Launch Statewide Prostate Cancer Education and Awareness Program MA, March 12, 2015—AdMeTech Foundation today announced the launch of a statewide prostate cancer education and awareness campaign supported by the Massachusetts Department of Public Health. The program, the first of its type statewide, also has the support of legislative leaders and advocacy groups, including the Massachusetts Prostate Cancer Coalition and Men of Color Health Awareness, a program of the YMCA of Greater Springfield.  The public launch of the program was announced at an annual prostate cancer awareness breakfast meeting organized by AdMeTech Foundation, a Boston non-profit bringing together legislators, advocates, and leading...
    READ MORE
  • Read More
    7th Annual Prostate Cancer Awareness Day Flyer
    April 6, 2015
    READ MORE
  • Read More
    AdMeTech Foundation announces launch of statewide prostate cancer awareness program
    March 12, 2015
    AdMeTech Foundation announces launch of statewide prostate cancer awareness program March 12th  AdMeTech Foundation today announced the launch of a statewide prostate cancer education and awareness campaign supported by the Massachusetts Department of Public Health. The program, the first of its type statewide, also has the support of legislative leaders and advocacy groups, including the Massachusetts Prostate Cancer Coalition and Men of Color Health Awareness, a program of the YMCA of Greater Springfield. The public launch of the program was announced at an annual prostate cancer awareness breakfast meeting organized by AdMeTech Foundation, a Boston non-profit bringing together legislators, advocates, and leading...
    READ MORE
  • Read More
    State to begin prostate cancer education program
    March 12, 2015
    State to begin prostate cancer education program March 12th BOSTON (AP) — Massachusetts is launching a new statewide campaign to raise awareness about prostate cancer. Organizers of the effort announced Thursday they hope to bring new approaches to screening, diagnosis and treatment of a common cancer among men that experts say is curable when detected early. AdMeTech Foundation, a nonprofit organization, is coordinating the public awareness campaign with support from the Massachusetts Department of Public Health. About 600 men in Massachusetts are expected to die from prostate cancer this year and the foundation says the mortality rate in the past among blacks has been...
    READ MORE
  • Read More
    AWARENESS EFFORT LAUNCHED TO HELP DETECT PROSTATE CANCER EARLY
    March 12, 2015
    AWARENESS EFFORT LAUNCHED TO HELP DETECT PROSTATE CANCER EARLY   By Colleen Quinn STATE HOUSE NEWS SERVICE STATE HOUSE, BOSTON, MARCH 12, 2015....Public awareness about the prevalence of prostate cancer will boost early detection and decrease medical costs associated with the disease, according to cancer survivors and a doctor involved with research. Thursday is annual Prostate Cancer Awareness Day. During a morning event at the Union Club, men who have had prostate cancer plan to describe why proper screening matters at an event that top legislative leaders plan to attend. One of the biggest barriers to fighting prostate cancer is the lack of early detection...
    READ MORE
  • Read More
    Western Massachusetts lawmakers team up with Boston non-profit to launch statewide prostate cancer awareness program
    March 12, 2015
    Massachusetts lawmakers team up with Boston non-profit to launch statewide prostate cancer awareness program   By Shira Schoenberg March 12th  BOSTON - In 2002, State Rep. Stephen Kulik, D-Worthington, was diagnosed with prostate cancer. The cancer was caught early during a routine annual physical, and Kulik underwent surgery and treatment. He has had a clean bill of health ever since. On Thursday morning, Kulik will join House Speaker Robert DeLeo, D-Winthrop, other legislators, advocates and doctors to kick off a statewide prostate cancer education and awareness program. "We feel that in many ways men are less open about discussing medical issues like this," Kulik said. "A...
    READ MORE
  • Read More
    Why It’s Time to Raise Awareness in the Fight Against Prostate Cancer
    February 23, 2015
    Why It's Time to Raise Awareness in the Fight Against Prostate Cancer February 23, 2015 By Dr. Faina Shtern, CEO, AdMeTech Foundation    Prostate cancer is curable when detected early, yet an American man dies from the disease every 18 minutes. Affecting one in seven men, this disease is even more common than breast cancer (which affects one in eight women), but public awareness and research funding to improve diagnosis and treatment are still lacking. That’s where AdMeTech Foundation – which works with some of the greatest minds in medicine, including doctors at Brigham and Women’s (BWH) and Massachusetts General Hospitals (MGH) and the...
    READ MORE
  • Read More
    A new genomic test (Decipher) from GenomeDx identifies men who after radical surgery for prostate cancer have a higher risk of the disease progression and may benefit from adjuvant radiation treatment
    February 13, 2015
    GenomeDx announces publication of positive validation study for Decipher Prostate Cancer Classifier February 10 GenomeDx Biosciences today announced the publication of a positive validation study for the Decipher® Prostate Cancer Classifier, a genomic test for prostate cancer. The study, published in the Journal of Clinical Oncology, showed that patients with low genomic risk (as determined by Decipher) may be optimally managed with observation after radical prostatectomy (prostate surgery), while those with high genomic risk (as determined by Decipher) may be better managed earlier with adjuvant radiotherapy. The identification of the right patients for post-operative radiation therapy and the timing of administering...
    READ MORE
  • Read More
    Researchers Look to MRI and Biomarkers to Help Improve Detection of Aggressive Prostate Cancers
    February 3, 2015
    Researchers Look to MRI and Biomarkers to Help Improve Detection of Aggressive Prostate Cancers                                                               January 28, 2015  A patient’s wife once told urology surgeon Peter Pinto, MD, that there was...
    READ MORE
  • Read More
    Senators Sessions and Boxer Introduce Bill to Support Prostate Cancer Research
    January 23, 2015
    Sessions, Boxer introduce bill to support prostate cancer research Jan, 22nd, 2015 WASHINGTON—U.S. Senators Jeff Sessions (R-AL) and Barbara Boxer (D-CA) today introduced legislation to fight prostate cancer. The National Prostate Cancer Plan Act would establish a council of federal agencies, patients, and medical experts charged with drafting and implementing a national strategy to combat prostate cancer. “Prostate cancer is one of the leading causes of cancer deaths in men. This legislation would help develop a national strategy to apply the best and most current medical thinking and approaches to preventing, treating, and ultimately curing prostate cancer,” said Senator Sessions. “Prostate cancer...
    READ MORE
  • Read More
    The National Prostate Cancer Plan Act Introduced By Senators Barbara Boxer and Jeffery Sessions
    January 23, 2015
    The National Prostate Cancer Plan Act Introduced By Sens Boxer And Sessions Wed, Jan 21st, 2015   U.S. Senators Barbara Boxer (D-CA) and Jeff Sessions (R-AL) today introduced legislation to fight prostate cancer. The National Prostate Cancer Plan Act would establish a council of federal agencies, patients, and medical experts charged with drafting and implementing a national strategy to combat prostate cancer. “Prostate cancer is one of the leading threats to the health and lives of American men,” said Senator Boxer. “We owe it to all of our families to do everything we can to fight this deadly disease.” “Prostate cancer is one of the leading causes of...
    READ MORE
  • Read More
    Researcher Makes Case for MRI Use in Prostate Biopsies
    November 4, 2014
    Oncologist Dr. Samir Taneja, right, and radiologist Dr. Andrew Rosenkrantz review an MRI ahead of a prostate biopsy at NYU Langone Medical Center. NYU LANGONE MEDICAL CENTER SUMATHI REDDY Nov. 3, 2014 5:12 p.m. ET   Every Friday and Monday, Samir Taneja conducts about six biopsies at NYU Langone Medical Center in New York to diagnose prostate cancer. Unlike conventional prostate biopsies, these procedures are guided by MRI images, which he says allows for more precise targeting. Dr. Taneja is one of a growing number of doctors and researchers investigating how MRI scans can be used to help detect and treat prostate cancer more effectively....
    READ MORE
  • Read More
    Senator Stephen M. Brewer, Chair Senate Committee on Ways and Means; and Representative Kulik, Vice Chair Joint Committee on Ways and Means
    October 9, 2014
    Senator Stephen M. Brewer and Representative Kulik By STEPHEN BREWER and STEPHEN KULIK Wednesday, October 8, 2014 (Published in print: Thursday, October 9, 2014) We would like to call attention to a disease that is more common and more lethal than even breast cancer in our state: Prostate cancer has become an epidemic, striking as many as one in seven men. This disease is personal — we are prostate cancer survivors. We know that when it strikes, it does not just strike men, but also impacts a man’s friends, family, and those who love him. This rampant disease leaves no family and...
    READ MORE
  • Read More
    FOX News: Doc: Women play key role in prostate cancer awareness
    September 22, 2014
    Doc: Women play key role in prostate cancer awareness By Dr. David B. Samadi Published September 09, 2014 FoxNews.com September is Prostate Cancer Awareness Month September marks Prostate Cancer Awareness Month, and as a result, women throughout the United States have a valuable addition to their to-do list.  We are urging women to take advantage of this month, and remind the men in their lives to get screened. According to the Prostate Cancer Foundation, 1 in 6 men are affected by prostate cancer in the U.S.  This makes it the most common cancer in America after skin cancer. This year, an estimated 238,000 men will be...
    READ MORE
  • Read More
    New imaging technique helps pinpoint treatment for prostate cancer
    September 22, 2014
    Houston Chronicle -- New imaging technique helps pinpoint treatment for prostate cancer By Kyrie O'Connor September 20, 2014 Melissa Phillip, Staff Dr. Brian J. Miles, a urologic oncologist, shows off Invivo's UroNav system at Houston Methodist. The system uses an MRI fusion technique to pinpoint areas for a biopsy. Bob Stearns knew prostate cancer might be in his future. His father had died of it in 1992, and several other relatives had succumbed to the illness. His urologist, Dr. Larry Lipschultz, monitored him carefully. In August 2007, when Stearns, a venture capitalist who lives in The Woodlands, was 57, Lipschultz found what seemed inevitable: cancer. Stearns became...
    READ MORE
  • Read More
    Prostate cancer death rate in Boston puzzles researchers
    September 19, 2014
    Prostate cancer death rate in Boston puzzles researchers Reason behind numbers unclear Friday, September 19, 2014 By: Lindsay Kalter Despite its status as a health care mecca, the Boston area has some of the highest numbers of prostate cancer-related deaths in the state, according to a local nonprofit health group. “If you look at prostate cancer mortality rates, you will see that statewide data would be probably lowest nationally. But if you start looking at Suffolk County, Boston specifically, that’s where the data are the worst,” said Dr. Faina Shtern, president of AdMeTech Foundation, a nonprofit supporting early detection and treatment of diseases. According to Shtern,...
    READ MORE
  • Read More
    Presidential Proclamation -- National Prostate Cancer Awareness Month, 2014
    August 31, 2014
    Prostate cancer is one of the most common cancers among American men. They are fathers, brothers, and sons -- and this year, more than 230,000 of them are expected to be diagnosed with this disease. During National Prostate Cancer Awareness Month, we honor all those whose lives have been touched by this disease, and we renew our commitment to reducing its devastating impact through more effective prevention, detection, and treatment...
    READ MORE
  • Read More
    Doctor Faina Shtern from AdMeTech Foundation joined NECN
    July 8, 2014
    July 8, 2014 Prostate cancer is the most common malignancy in Massachusetts, with a higher mortality rate than breast cancer. The Massachusetts House and Senate have approved a new education and awareness program trying to change that. Doctor Faina Shtern from AdmeTech Foundation joined NECN with details. She said the approval will bring the knowledge and technology from world-leading institutions to every health care provider in the state. She said she believes it will put Massachusetts in the leadership position of dealing with prostate cancer.
    READ MORE
  • Read More
    On June 30, The Massachusetts’ House of Representatives and Senate created a new education and awareness program dedicated to prostate cancer.
    July 7, 2014
    On June 30, The Massachusetts’ House of Representatives and Senate created a new education and awareness program dedicated to prostate cancer. The $500,000 campaign, contained in the conference committee report of the FY15 budget, is aimed at saving lives, improving quality of life, and reducing health care costs. This program will be managed by the Department of Public Health and uniquely focused on men with African American roots, family history and other individuals at high risk of lethal prostate cancer. "I commend the legislative members of the conference committee for creating a Massachusetts...
    READ MORE
  • Read More
    Commissioner, Massachusetts Department of Public Health's Blog
    June 25, 2014
    Organized by the AdMeTech Foundation in cooperation with the Massachusetts Prostate Cancer Coalition and Men of Color Health Awareness Project, Prostate Cancer Awareness Day highlights our common goal to make Massachusetts a model of national leadership in prostate cancer research, education, and awareness resulting in improved patient care. After skin cancer, prostate cancer is the most common major cancer in men – and one of the most lethal. Research has shown that family history, age, and ethnicity can be factors that contribute to a man’s chance of having prostate cancer.  But when it comes to the successful treatment of...
    READ MORE
  • Read More
    Prostate Cancer Awareness Day at the MA State House
    June 20, 2014
    Prostate Cancer Awareness Day By Colleen Quinn June 20, 2014 Prostate cancer discriminates, Mayor Martin J. Walsh of Boston told a crowd at the State House gathered Thursday to increase awareness of the disease that kills nearly 30,000 American men each year. African-American men are 60 percent more likely to be diagnosed with prostate cancer and 250 times more likely to die from the disease than men in any other ethnic group, say advocates who held the sixth annual Prostate Cancer Awareness Day. Walsh, a childhood cancer survivor,...
    READ MORE
  • Read More
    "Prostate cancer discriminates", Mayor Martin J. Walsh of Boston told a crowd at the State House...
    June 20, 2014
    Prostate cancer discriminates, Mayor Martin J. Walsh of Boston told a crowd at the State House gathered Thursday to increase awareness of the disease that kills nearly 30,000 American men each year. African-American men are 60 percent more likely to be diagnosed with prostate cancer and 250 times more likely to die from the disease than men in any other ethnic group, say advocates who held the sixth annual Prostate Cancer Awareness Day. Walsh, a childhood cancer survivor, said, “We have to end the silence around prostate cancer.” Prostate cancer is the second leading cause of death...
    READ MORE
  • Read More
    Politicians across the aisle put aside their differences for the sixth annual Prostate Cancer Awareness Day at the State House
    June 20, 2014
    Politicians across the aisle put aside their differences for the sixth annual Prostate Cancer Awareness Day at the State House in order to promote the education and prevention of prostate cancer. The event, sponsored by the AdMeTech Foundation, highlighted the critical importance of early detection and efforts to improve screening of prostate cancer, the second-leading cause of cancer death in American men. “Boston is home to some of the best hospitals and doctors in the world, and if we work together we can save thousands of lives and ensure that men are getting the highest quality,...
    READ MORE
  • Read More
    AdMeTech Foundation hosted the state’s sixth annual Prostate Cancer Awareness Day June 19
    June 20, 2014
    BOSTON – In a full-court press effort to highlight the critical importance of early detection of prostate cancer, AdMeTech Foundation hosted the state’s sixth annual Prostate Cancer Awareness Day June 19, bringing together House Speaker Robert DeLeo, Senate President Therese Murray, Boston Mayor Martin Walsh, Public Health Commissioner Cheryl Bartlett, Marathon legend and prostate cancer survivor Bill Rodgers and leading medical experts. The Statehouse event focused on making Massachusetts the national leader in awareness of and education about prostate cancer. Prostate cancer is the most common major malignancy in the U.S. and...
    READ MORE
  • Read More
    in seven men will be diagnosed with prostate cancer in his lifetime
    June 19, 2014
    Prostate Cancer Awareness Day BOSTON (WWLP) – One in seven men will be diagnosed with prostate cancer in his lifetime. The problem is so widespread that one American will die from complications from prostate cancer every 18 minutes. Daunting statistics like these stress the importance of early detection. In this year alone, about 233,000 men will be diagnosed with prostate cancer in this country, and men in western Massachusetts should be particularly concerned, says Antonio Delesline of the Men of Color Health Alliance. “It’s...
    READ MORE
  • Read More
    AdMeTech Foundation's 6th Annual Prostate Cancer Awareness Day
    June 19, 2014
    Mayor Walsh joins Senate President Therese Murray, speaker of the house Robert DeLeo, Marathon legend Bill Rodgers, and Boston media icon Susan Wornick in kicking off the AdMeTech Foundation's 6th Annual Prostate Cancer Awareness Day. All expressed concern that Prostate cancer discriminates against African American men. See Video.
    READ MORE
  • Read More
    Democrats, Republicans, Independents, "We All Agree"
    June 12, 2014
    DEMOCRATS, REPUBLICANS, INDEPENDENTS ALL AGREE   Gubernatorial Candidates Highlight Need for Prostate Cancer Awareness in AdMeTech Foundation’s New “We All Agree” Video Prostate Cancer Awareness Day Set for June 19th BOSTON, MA, June 11, 2014—Eight candidates running to be the next Governor of Massachusetts appeared together in “We All Agree,” a video released today by the non-profit AdMeTech Foundation, creator of The Manogram® Project. The video highlights the need for increased prostate cancer education and awareness in the Commonwealth, and was produced in connection with the upcoming 6th Annual Prostate Cancer Awareness Day at the State House. Joe Avellone (D), Charlie Baker (R), Martha...
    READ MORE
  • Read More
    Four Democrats, two Republicans, and two independent candidates running for Governor support prostate cancer awareness
    June 12, 2014
    The Republican BOSTON — It's not often that you can get seven political candidates all seeking the same office to agree on something. Four Democrats, two Republicans, and two independent candidates running for governor took time out of their campaign schedules this month to record a video to raise awareness about prostate cancer. The video was recorded in the run up to the state's Sixth Annual Prostate Cancer Awareness Day on June 19. Recent studies show that prostate cancer is responsible for more...
    READ MORE
  • Read More
    Eight Massachusetts gubernatorial candidates took time off from the campaign trail to record a video raising awareness of prostate cancer.
    June 11, 2014
    Prostate Cancer Awareness Day BOSTON — Eight Massachusetts gubernatorial candidates took time off from the campaign trail to record a video raising awareness of prostate cancer. “As candidates we don’t agree on everything, but we do agree on this,” Martha Coakley, the Democratic frontrunner, says in the video called “We All Agree.” The PSA, from the nonprofit AdMeTech Foundation, urges men in the state to get screened for early detection and treatment. “Did you know that prostate cancer is more common and more lethal than...
    READ MORE
  • Read More
    Boston Business Journal: Public Health Commissioner Bartlett Recognized by AdMeTech Foundation
    June 3, 2014
    Boston Business Journal: People on the Move Cheryl Bartlett, Massachusetts Department of Public Health Commissioner, was recognized as a key leader for highlighting the need for public education and awareness of prostate cancer in Massachusetts by AdMeTech Foundation at an event on April 3. Read More
    READ MORE
  • Read More
    Boston Globe: Top state legislators support prostate cancer awareness and The Manogram Project
    April 15, 2014
    By Mike Deehan State House News Service   April 15, 2014  Chairman of the Senate Ways and Means CommitteeStephen Brewer is a prostate cancer survivor. Three members of the Massachusetts Legislature are speaking out about their own battles against prostate cancer in an effort to elevate awareness of the threat and screening options. The chairman of the Senate Ways and Means Committee, Stephen Brewer; Senator Kenneth Donnelly; and the vice chairman of the House Ways and Means Committee, Stephen Kulik, are all prostate cancer survivors and support creation of a statewide program for prostate cancer education and awareness. Among the practices Brewer and the...
    READ MORE
  • Read More
    5th Annual Prostate Cancer Awareness Day in Mass
    February 28, 2014
    It was an important day when it comes to men's health: fifth annual prostate cancer awareness day in Massachusetts. The day was established in order to raise awareness and recognize prostate cancer as a public health priority. “This is a very important cancer,” says Dr. Jennifer Yates, a urologist at UMass Memorial. “It’s one of the most common cancers that affects men.” Dr. Yates recommends that men over the age of 55 have a conversation about getting screened for prostate cancer. “We have a couple of tools that help us screen including a rectal exam and a blood test...
    READ MORE
  • Read More
    AdMeTech Has Moved to One Boston Place
    December 1, 2013
      AdMeTech Foundation has Moved!   We would like to inform everyone that our new address is     AdMeTech Foundation One Boston Place, 26th Floor Boston, MA 02109     Our phone number will remain 617.523.3535 but if you are having any difficulties, you may dial 857.239.8869 as well. Please take a minute to update your address book and contacts. Our website and emails will remain the same.     Thank you.       Join us on Facebook       Follow us on Twitter      Send us an Email
    READ MORE
  • Read More
    Senator Elizabeth Warren pushes for more funding for biomedical research at NIH
    October 29, 2013
    “Warren: Boost medical research spending,” by Deirdre Fernandes, Globe Staff, published October 28, 2013. Read the full Boston.com article here. Addressing a Greater Boston Chamber of Commerce forum, Senator Elizabeth Warren (D-MA) announced her support for more consistent funding for the National Institutes of Health (NIH) for more biomedical research to save both lives and money, as well as to promote economic growth throughout the country. This is especially relevant in her home state of Massachusetts, where hospitals and research universities, which receive funding from NIH, are driving economic factors. Massachusetts has long been a pioneer in health research, including understanding and treating...
    READ MORE
  • Read More
    'Dancing with the Stars' Cast Dances for a Cure in Boston
    February 4, 2013
    This weekend, AdMeTech Foundation hosted an evening of dining, dancing, black ties, and donations for a good cause. The Dance for a Cure fundraising event took place on Saturday at The Westin in Copley Place, with professional dancers from ABC's Dancing with the Stars in attendance. Mark Ballas, Emmy-nominated professional ballroom dancer and cast member of Dancing with the Stars, began the program by getting all of the attendees off their feet for a lesson. When most women in their gowns looked around modestly, as if just being in the presence of the lively and handsome dancer was enough, Ballas threw his...
    READ MORE
  • Read More
    Mark Ballas and ‘Dancing With the Stars’ personalities in Boston for ‘Dance for a Cure’
    February 4, 2013
    More than 600 guests got the chance to see “Dancing With the Stars” personalityMark Ballas (far right) move to the beat at AdMeTech Foundation’s “Dance for a Cure” at the Westin on Saturday night. Co-sponsored by Arthur Murray International, the benefit for prostate cancer research drew “Dancing With the Stars” talent Anna Trebunskaya, who’s been paired with Chuck Liddell and Drew Lachey; Jonathan Roberts, who’s danced with Macy Gray and Marie Osmond; and Louis van Amstel, who came in third in season 9 when he danced with Kelly Osbourne. Also there were dance champion and “Dancing With the Stars” choreographer Nick Kosovich (near right) and WCVB-TV’s Susan Wornick, the night’s emcees. Worth noting:...
    READ MORE
  • Read More
    Reuters Covers Arthur Murray Teach-A-Thon
    August 27, 2012
    Reuters BOSTON, Jan. 23, 2012  "Teach-a-Thon" to Benefit AdMeTech Foundation's Dance for a Cure of Prostate Cancer BOSTON, Jan. 23, 2012 /PRNewswire-USNewswire/ --The following is being released by AdMeTech Foundation: WHAT: On January 27, 2012, between noon and midnight Arthur Murray Dance Studio ofBoston is taking dance steps with its 4th Annual Teach-A-Thon to benefit AdMeTech Foundation's Dance for a Cure of Prostate Cancer. "One in six men is diagnosed with prostate cancer, and every 16 minutes a man dies. There is no community in the United States left untouched," said AdMeTech Foundation's President, Dr. Faina Shtern "Arthur Murray's...
    READ MORE
  • Read More
    Advocates, Pols Aim To Raise Prostate Cancer Awareness
    June 28, 2012
    READ MORE
  • Read More
    Senator Boxer (D-CA) and Rep. Cummings (D-MD) Introduce Historic Legislation to Promote Prostate Cancer Research
    June 27, 2012
    U.S. Senator Barbara Boxer (D-CA) and Congressman Elijah Cummings (D-MD) have introduced groundbreaking legislation authorizing $180 million in new federal spending for improved early detection of prostate cancer, a health care epidemic which now strikes an American man every 2.5 minutes and claims the life of an American man every 16 minutes. Moreover, African American men have a 60% higher incidence and a 250% higher mortality than any other ethnic group. The Boxer-Cummings bill comes as political, advocacy and medical leaders converged at the State House today in support of advancement of early detection of prostate cancer, which is critical...
    READ MORE
  • Read More
    MRI reporting tool could revolutionize prostate imaging
    February 10, 2012
    MRI reporting tool could revolutionize prostate imaging February 10, 2012 by Brendon Nafziger , DOTmed News Associate Editor Imaging advocates say new reporting tools for MRI prostate scans could help make the modality more useful for men and possibly one day eliminate thousands of unnecessary prostate biopsies. Currently, an international effort from radiologists is underway to standardize the reporting of MRI prostate scans in an effort to make the interpretation of scans more uniform. The results could make data-gathering for clinical studies easier and also ensure patients at last fully benefit from new MRI technologies that might transform the way prostate cancer cases are...
    READ MORE
  • Read More
    International Scientific Cooperation to Advance Image-Guided Prostate Cancer Care
    February 7, 2012
    American College of Radiology International Scientific Cooperation to Advance Image-Guided Prostate Cancer Care American College of Radiology (ACR), AdMeTech Foundation and European Society of Urogenital Radiology (ESUR) Create Standards for High Quality MRI February 07, 2012 To improve early diagnosis and treatment of prostate cancer, ACR, AdMeTech Foundation and ESUR have formed a joint effort to expedite development of standards for the Magnetic Resonance Prostate Imaging Reporting and Data System (MR PI-RADS) modeled after a successful effort in breast cancer care. The goal is to expedite the...
    READ MORE
  • Read More
    Arthur Murray Boston's 2012 Teach-a-thon to Benefit AdMeTech Foundation's Dance for a Cure
    January 27, 2012
    On January 27, 2012, between noon and midnight Arthur Murray Dance Studio of Boston is taking dance steps with its 4th Annual Teach-A-Thon to benefit AdMeTech Foundation’s Dance for a Cure of Prostate Cancer. “One in six men is diagnosed with prostate cancer, and every 16 minutes a man dies. There is no community in the United States left untouched,” said AdMeTech Foundation’s President, Dr. Faina Shtern “Arthur Murray’s teachers are inviting everyone to dance for our fathers, brothers, husbands, partners, friends and neighbors who have faced or lost their battle against prostate cancer,” stated Kia Kenney, Manager of Arthur Murray Dance Studio of Boston. “Arthur Murray Dance Studio of Boston will conduct a...
    READ MORE
  • Read More
    Arthur Murray Dance Studio of Boston Takes Steps to End the Prostate Cancer Crisis
    January 23, 2012
    On January 27, 2012, between noon and midnight Arthur Murray Dance Studio of Boston took dance steps with its 4th Annual Teach-A-Thon to benefit AdMeTech Foundation's Dance for a Cure of Prostate Cancer. "One in six men is diagnosed with prostate cancer, and every 16 minutes a man dies. There is no community in the United States left untouched," said AdMeTech Foundation's President, Dr. Faina Shtern.  "Arthur Murray's teachers are inviting everyone to dance for our fathers, brothers, husbands, partners, friends and neighbors who have faced or lost their battle against prostate cancer," stated Kia Kenney, Manager of Arthur Murray Dance Studio of Boston. Read More
    READ MORE
  • Read More
    Key Massachusetts Legislators Lead the Nation in Declaring Prostate Cancer a Public Health Priority
    September 19, 2011
    Senate President Therese Murray, jointly with Speaker of the House Robert DeLeo set a historic precedent by declaring prostate cancer as a public priority, central challenge in men's health and a major disparity issue.  The Senate President introduced the Massachusetts General Court Resolutions at the Third Annual Prostate Cancer Awareness Day at the Massachusetts State House onThursday, September 15. The Resolutions recognized AdMeTech Foundation, the Boston-based nonprofit that hosted the event in cooperation with Boston Bruins Icon Mike Milbury, leaders of medicine and advocacy groups, including the Massachusetts Prostate Cancer Coalition, US Too International, Prostate Health Education Network, and with support...
    READ MORE
  • Read More
    Massachusetts Legislators, Advocates and Physicians to Declare Prostate Cancer a Public Health Priority at State House Event
    September 15, 2011
    Massachusetts leaders will gather at the State House today for Prostate Cancer Awareness Day to proclaim prostate cancer as a public priority in Massachusetts and a health care crisis in African American men, and discuss recent advances in early diagnosis and treatment. Senate President Therese Murray will announce a Governor's Proclamation of September 15 as a Massachusetts Prostate Cancer Awareness Day for the first time in the history of the state. Read More
    READ MORE
  • Read More
    Celebrities, Leaders of Medicine Support AdMeTech and Dance for a Cure
    August 30, 2011
    Attendees included Actress (Brady Bunch) Florence Henderson; internationally renowned dancer, actress (Fame), and choreographer Debbie Allen; ABC’s Dancing with the Stars cast members Corky Ballas, Mark Ballas, Karina Smirnoff, and Louis van Amstel, and choreographer Nick Kosovich; FOX’s So You Think You Can Dance judge Mary Murphy; Oxygen’s Dance Your A** Off executive producer and actress (Shall We Dance? with Richard Gere) Lisa Ann Walter; award-winning Broadway choreographer (Memphis) Sergio Trujillo; and Hollywood DanceSport Championship’s Michael Chapman. They were joined by leaders in medicine, including Faina Shtern, M.D., President of the AdMeTech Foundation;Mark Scholz, M.D., Executive Director of the Prostate Cancer Research Institute, faculty member at the University of Southern California, and author of the recently published book “Invasion of the Prostate...
    READ MORE
  • Read More
    Superstars of Dance Choreograph Prostate Cancer Awareness to Benefit Creation of Manogram®
    June 16, 2011
    Prestigious national ballroom competition Yankee Classic stages professional celebrities of the ABC TV megahit show Dancing with the Stars (DWTS) in support of the AdMeTech Foundation's quest to create Manogram™: Life-saving imaging for men. Yankee Classic will feature Dance for a Cure Championships to benefit AdMeTech Foundation's programs in research and awareness which are aimed at creating accurate diagnostic tools for prostate cancer akin to life-saving mammography for breast cancer. While prostate cancer strikes 1 in 6 men and has become even more common than breast cancer (striking 1 in 8 women), men do not have reliable tools...
    READ MORE
  • Read More
    FOX Business News Covers AdMeTech's "Manogram Project"
    March 4, 2011
    FOX Business News Covers AdMeTech's "Manogram Project"May. 04, 2011 - 4:09 - Admetech Foundation Founder Dr. Faina Stern on why medical screening needs to be improved. See Video
    READ MORE
  • Read More
    "Men Need a Man-O-Gram" Article featured in PCRI Insights
    March 1, 2011
    Dr. Mark Scholz, Executive Director at the Prostate Cancer Research Institute, highlights the work of AdMeTech and calls for the need for early detection and improved diagnostics in prostate cancer care.
    READ MORE
  • Read More
    Center for Molecular Imaging Innovation and Translation
    February 22, 2011
    The time has come, say medical experts from around the country, to advance medical care of prostate cancer—with molecular imaging leading the way. “We have a prostate cancer crisis,” says Faina Shtern, M.D., president and CEO of the AdMeTech Foundation. “There is an opportunity for imaging to transform patient care and end this crisis.” Read More
    READ MORE
  • Read More
    Society of Nuclear Medicine Coverage
    February 1, 2011
    Society of Nuclear Medicine features AdMeTech’s research and advocacy efforts. Bringing Prostate Cancer into the Light The time has come, say medical experts from around the country, to advance medical care of prostate cancer—with molecular imaging leading the way. “We have a prostate cancer crisis,” says Faina Shtern, M.D., president and CEO of the AdMeTech Foundation. “There is an opportunity for imaging to transform patient care and end this crisis.” Read More
    READ MORE
  • Read More
    Florence Henderson, Debbie Allen, Celebrities of ABC's Dancing with the Stars & FOX's So You Think You Can Dance Choreograph 'Dance for the Cure of Prostate Cancer' at the Hollywood DanceSport Championships
    November 11, 2010
    Florence Henderson; internationally renowned dancer, actress (Fame), and choreographer Debbie Allen; ABC's Dancing with the Stars cast members Corky Ballas,Mark Ballas, Karina Smirnoff, and Louis van Amstel, and choreographer Nick Kosovich; FOX's So You Think You Can Dance judge Mary Murphy; Oxygen's Dance Your A** Off executive producer and actress (Shall We Dance? with Richard Gere) Lisa Ann Walter; award-winning Broadway choreographer (Memphis) Sergio Trujillo; and Hollywood DanceSport Championship's Michael Chapman. They were joined by leaders in medicine, including Faina Shtern, M.D., President of the AdMeTech Foundation;Mark Scholz, M.D., Executive Director of the Prostate Cancer Research Institute, faculty member at the University of Southern California, and author of the recently published book "Invasion of the Prostate Snatchers"; and Stefka Koenig, Director...
    READ MORE
  • Read More
    Scientific Panel Cites Promise of MRI to Improve Prostate Cancer Diagnostics, Supports Federal Funding to End Public Health Crisis
    May 10, 2010
    A group of leading U.S. and international scientists and clinicians issued a consensus statement today identifying prostate cancer as a public health crisis and endorsing the promise of MRI for improved early detection and treatment. They also highlighted the leadership of the U.S. Congress in introducing legislation to fund research into improving prostate cancer diagnostics. Convening last week at the annual meeting of the International Society of Magnetic Resonance in Medicine in Stockholm, Sweden, members of the AdMeTech Foundation's International Prostate Cancer MRI Working Group offered their endorsement after reviewing new and emerging scientific data from major academic institutions...
    READ MORE
  • Read More
    Officials Help in Cancer Fight
    September 7, 2009
    Sen. Stephen M. Brewer, D-Barre, and Rep. Stephen Kulik, D-Worthington, both survivors of prostate cancer, are teaming up to promote early detection of the disease and possibly save some lives. Kulik, who had his prostate removed seven years ago, and Brewer, who had the same surgery in February, said they are suffering no ill effects and they feel great. Read More
    READ MORE
  • Read More
    The Man, The Gland, The Dilemma
    April 18, 2009
    Groundbreaking, three-part coverage of AdMeTech’s research program in prostate MRI and its potential impact on screening, diagnosis and treatment by the Wall Street Journal.One evening a week for more than 10 years, a group of 15 to 25 men have met in a conference room in New York to talk about their prostate cancer. In the beginning, most of them swapped stories about their surgery or radiation, says Darryl Mitteldorf, a social worker who runs the group. Now, he says, more...
    READ MORE
  • Read More
    Prostate Cancer: Weighing Options
    April 7, 2009
    Groundbreaking, three-part coverage of AdMeTech’s research program in prostate MRI and its potential impact on screening, diagnosis and treatment by the Wall Street Journal.You've been diagnosed with prostate cancer and after the shock comes confusion. Should you treat it fast with surgery but face an immediate risk of sexual and urinary problems? Or should you opt for weeks of daily radiation treatments and side effects that set in more slowly? Should you also use hormone therapy that may shrink the cancer --...
    READ MORE
  • Read More
    Weighing the Benefits of "Watchful Waiting"
    March 31, 2009
    Groundbreaking, three-part coverage of AdMeTech’s research program in prostate MRI and its potential impact on screening, diagnosis and treatment by the Wall Street Journal.You've been getting annual blood tests to check for prostate cancer. But two big studies in the New England Journal of Medicine just found that screening for PSA -- prostate specific antigen -- doesn't save many lives. Should you keep checking it? Your biopsy was negative for prostate cancer but your PSA keeps rising. Should you stop worrying --...
    READ MORE
  • Read More
    NBC Covers AdMeTech's "Manogram Project"
    March 19, 2009
    NBC News Covers AdMeTech's "Manogram Project"One in six men are diagnosed with prostate cancer. But there's an even bigger question mark on whether healthy men should get psa tests to screen for it. The test does save lives, but for every life saved dozens more are either misdiagnosed or treated needlessly exposing them to harmful side effects. Two huge new studies back up what experts already knew: that the psa test for prostate cancer may hurt more men than it helps. Mitch Laurence is a six year...
    READ MORE
  • Read More
    Experts urge prostate cancer "man-o-gram"
    January 15, 2009
    Prostate cancer experts urged Congress and the incoming Obama administration on Wednesday to make a major research commitment to find better detection methods, including what they call a "man-o-gram." Their idea involves a sophisticated ultrasound, magnetic resonance imaging or other method to find dangerous prostate tumors, akin to the common mammogram scans used to find breast tumors. Read More
    READ MORE
  • Read More
    HR 353 passed unanimously in the US House of Representatives, with strong bi-partisan support
    June 26, 2008
    READ MORE
  • Read More
    The Fourth Public Conference on Image-Guided Diagnosis and Treatment of Prostate Cancer
    September 20, 2007
    The Fourth Public Conference on Image-Guided Diagnosis and Treatment of Prostate Cancer brought together key leaders of academia, industry and advocacy. During a closing ceremony in US Congress, when the $650 million Prostate Cancer Research and Imaging (PRIME) Act was introduced by Rep. Elijah Cummings in the US House of Representatives. See Press Coverage below:
    READ MORE
  • Read More
    Dr. Bruce Hensel Covers AdMeTech's "The Manogram Project"
    October 1, 2005
    Dr. Bruce Hensel, Chief Medical Correspondent for NBC TV in Los Angeles highlights the importance of diagnostic imaging for prostate cancer care and supports the Manogram® Project.Dr. Bruce Hensel, Chief Medical Correspondent for NBC TV in Los Angeles highlights the importance of diagnostic imaging for prostate cancer care and supports the Manogram® Project. Watch Video
    READ MORE


		

	





	


	


			

		


	
	


	

	
	
	


		



    

        


			
                


					©2022 AdMeTech Foundation. All rights reserved. One Boston Place, 26th Floor, Boston, MA 02108 Tel: 617-523-3535 Fax: 617-507-2439 Email: contact@admetech.org

                


			
            


				
            


        

    



	



	Go to Top